The custom targeted BRCAplus test includes comprehensive analyses of all 92 coding exons in six high-risk breast cancer susceptibility genes: BRCA1, BRCA2, CDH1, PTEN, TP53, and STK11 (Table 1). This evidence concerns the gene STK11 and breast cancer.